Introduction
The overexpression of E2F-1 or mutated forms of E2F-1 in serum-starved or actively growing fibroblasts Normal growth and development involve competing procan trigger apoptosis (Qin et al., 1994 ; Shan and Lee, cesses of cell proliferation and apoptotic cell death.
1994; Wu and Levine, 1994; Kowalik et al., 1995 ; Krek et Transcription factors of the E2F family, comprised of al., 1995) raising the possibility that E2F-1 may regulate E2F-1-E2F-5, have been suggested to play a key role genes important for cell death. Another possible funcin the regulation of cell proliferation (La Thangue, 1994;  tion is suggested by the observation that Rb-bound Adams and Kaelin, 1995; Weinberg, 1995) . First, E2F
E2F-1 can still interact with its cognate DNA sequence binding sites are crucial for transcriptional activation element and thus repress the transcription of certain of genes that regulate S phase entry-such as c-myc cell cycle regulatory genes (Bandara et al., 1991; Chel-(Hiebert et al., 1989; Huang and Hearing, 1989; Thalmeier lappan et al., 1991; Chittenden et al., 1991; Weintraub et al., 1989), cyclin D (Motokura and Arnold, 1993; Sala et al., 1992 Sala et al., , 1995 Neuman et al., 1995; Sellers et al., et al., 1994) , and cyclin E (DeGregori et al., 1995; Duronio 1995) . This finding has prompted the hypothesis that, and O'Farrell, 1995)-and genes that function to engage by repressing transcription, the Rb/E2F-1 complex may DNA synthesis-such as dihydrofolate reductase (Blake play an active role in suppressing progression through and Azizkhan, 1989; Mudryj et al., 1990) , thymidine ki-G1 until an appropriate signal triggers Rb phosphorylanase (Dou et al., 1992; Ogris et al., 1993) , and DNA tion and its release from E2F . polymerase ␣ (Pearson et al., 1991; Sala et al., 1994;  Despite considerable progress in elucidating the mul- DeGregori et al., 1995) . Second, the activity of E2Fs as tiple potential functions of E2F-1 during cell proliferatranscription factors is regulated by their interaction tion, a potential limitation of the studies so far is their with other components of the cell cycle machineryuse of overexpression of wild-type or mutant versions of E2F-1 under conditions where wild-type E2F-1 was present and functional. Thus, it is uncertain whether the The E2F-1 gene replacement construct is derived from a 7.4 kb fragment of the E2F-1 gene disrupted in exon 3 by the PGK-neo selectable marker. In addition, exon 4 is deleted. Adjacent to the E2F-1 DNA is the negative selectable marker (PGK HSV-TK). Restriction enzyme recognition sites are abbreviated as follows: E, EcoRV; S, SacI; Sm, SmaI; X, XcmI; H, HindIII; C, ClaI.
(B) Southern hybridization demonstrates the presence of the targeted E2F-1 mutation in mice. Mouse genomic DNA was digested with the restriction enzyme EcoRV, and analyzed by Southern blotting using an E2F-1 genomic probe (as depicted in [A] ). The wild-type E2F-1 gene yields a band of 3.0 kb, while the mutant gene yields a band of 2.3 kb. Southern hybridization using other restriction enzymes and both 5Ј and 3Ј E2F-1 genomic probes demonstrates that the structure of the mutant gene is as expected in mice derived from all three ES cell lines (data not shown). Further, these data and the use of a probe for neo sequences indicate that additional copies of the gene targeting construct do not exist elsewhere in the genome (data not shown).
(C) Northern hybridization demonstrates that the homozygous E2F-1 mutation abolishes E2F-1 mRNA expression. RNA was harvested from cells arrested in S phase from two wildtype and two E2F-1 Ϫ/Ϫ mice and used for Northern hybridization with a probe derived from the 3Ј coding region of the human E2F-1 cDNA (see Experimental Procedures).
As shown, wild-type fibroblasts express an ‫0.3ف‬ kb message corresponding to the E2F-1 mRNA. This mRNA is not present in the E2F-1 homozygous mutant fibroblasts. The integrity and amount of RNA in each lane was demonstrated by stripping and rehybridizing the same blot with a probe specific for the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA. S phase, suppress G1 progression, and/or regulate mutations abolish the ability of E2F-1 to bind DNA, activate transcription, drive cell cycle progression, or trigger apoptosis. To address this issue, we generated and studied E2F-1 deficient mice. Although these mice were apoptosis (Helin et al., 1992; Kaelin et al., 1992; Cress et al., 1993; Johnson et al., 1993; Shan and Lee, 1994) . found to develop and reproduce normally, they exhibited a number of defects in T cell development indicating
The E2F-1 targeting construct also deletes E2F-1 exon 4, encoding the leucine zipper and part of a "marked that E2F-1 functions to positively regulate apoptosis and suppress cell proliferation. E2F-1 appears not to be box" protein-protein interaction domain (Kaelin et al., 1992; Lees et al., 1993) . Therefore, any RNA transcripts critical for entry into S phase. Rather, this function may be served by other members of the E2F family. Taken expressed from the mutated E2F-1 locus should not encode a functional protein. Gene-targeted J1 embrytogether with previous findings demonstrating that E2F-1 can cause oncogenesis when overexpressed, the onic stem (ES) cell lines were used to produce mice heterozygous for the E2F-1 mutation. Heterozygotes observations described here reveal that a single gene, depending on its level of expression or cellular environ-(ϩ/Ϫ) were intercrossed to generate homozygous mutant mice (Ϫ/Ϫ), as demonstrated by Southern hybridment, can function as either an oncogene, or paradoxically, as a suppressor of cell proliferation. ization ( Figure 1B ). Homozygotes produced from three independent ES cell clones were bred into both 129/Sv and 129/Sv ϫ C57BL/6 backgrounds and gave similar Results results in all experiments described here. RNA expression of primary embryonic fibroblasts isoTargeted Mutation of the E2F-1 Gene A 7.4 kb fragment of the E2F-1 gene was used to generlated from wild-type and E2F-1 Ϫ/Ϫ mouse embryos was examined by Northern analysis. Fibroblasts were synate a targeting vector in which the DNA binding and dimerization domains of the E2F-1 gene were disrupted chronized at the start of S phase by exposure to hydroxyurea. Under these conditions, E2F-1 mRNA exby the insertion of a PGK-neo cassette ( Figure 1A ). The site of insertion lies within a region of E2F-1 in which pression is maximal (Kaelin et al., 1992; Li et al., 1994) , and wild-type fibroblasts express a 3.0 kb E2F-1 tranwith progenitors from the bone marrow, increased proliferation of thymocytes within the thymus, failure of mascript ( Figure 1C ). This transcript was not detected in ture thymocytes to leave the thymus, or a decreased the E2F-1 Ϫ/Ϫ fibroblasts indicating that the engineered rate of thymocyte death. mutation successfully disrupted E2F-1 mRNA expresTo investigate these possibilities, the developmental sion and therefore E2F-1 function.
profiles of thymocytes from E2F-1 Ϫ/Ϫ and wild-type mice were compared. By monitoring the expression of the E2F-1 is Not Essential for Overall CD4 and CD8 cell surface markers, the extent of thymoDevelopment or Survival cyte maturation was assessed. As thymocytes mature E2F-1 Ϫ/Ϫ mice are born and appear overtly normal. Of they progress sequentially through double-negative 351 mice born to crosses of E2F-1 ϩ/Ϫ mice, 97 (28%) (
, and singlewere of the ϩ/ϩ, 172 (49%) of the ϩ/Ϫ, and 82 (23%) positive (CD4 al., 1988) . Upon staining with anti-CD4 and anti-CD8 and Ϫ/Ϫ mice were equally viable. Moreover, crosses antibodies, thymuses of four-to six-week-old E2F-1
between E2F-1 Ϫ/Ϫ mice also produced overtly normal mice were found consistently to contain a higher fraction offspring. Although E2F-1 Ϫ/Ϫ mice weighed 17% less of mature thymocytes (CD4 ϩ or CD8 ϩ ) than wild-type than wild-type littermates for at least the first 8 months littermates ( Figure 3C ). To establish further the identity of life (p < 0.01, n ϭ 56 wild type, n ϭ 43 E2F-1
of the population of thymocytes expanded in the E2F-obvious gross or microscopic abnormalities were noted 1 Ϫ/Ϫ mice, thymocytes were stained with an antibody to in the liver, brain, gut, cardiac or skeletal muscle, bone, CD3⑀, a component of the T cell receptor expressed spleen, kidneys, or pancreas at four to six weeks of age.
at high levels in mature cells. The percent of CD3⑀ hi Thus, E2F-1 is not required for overall development, thymocytes was significantly increased in E2F-1 Ϫ/Ϫ survival, or reproduction of mice.
compared with wild-type mice (44% Ϯ 12% versus 18% Since the E2Fs are believed to play a crucial role in Ϯ 3% in a typical experiment), supporting the conclusion regulating the G1/S transition, we examined the requirethat in the absence of E2F-1 the fraction of mature thyment for E2F-1 in cell proliferation and cell cycle promocytes is increased. Taking into account the total numgression. Surprisingly, in E2F-1 Ϫ/Ϫ primary embryonic ber of thymocytes per thymus, the absolute number of fibroblasts, the doubling time, cell cycle distribution, cells in all thymocyte populations is increased in E2F-and timing of reentry into the cell cycle from G0 were 1 Ϫ/Ϫ mice ( Figure 3D ). The E2F-1 Ϫ/Ϫ mice exhibit a small indistinguishable from that of wild-type fibroblasts (Fig- increase in the absolute number of immature (CD4/ ures 2A and 2B). Likewise, when lymph node cells from CD8 double-negative and double-positive) thymocytes. four-to six-week-old E2F-1 Ϫ/Ϫ mice and wild-type litHowever, E2F-1 Ϫ/Ϫ mice exhibit a larger, selective intermates were compared, they were found to respond crease in the number of mature (CD4/CD8 single-posito mitogenic signals equally well ( Figure 2C ). Cell protive) thymocytes. Although the smaller increase in the liferation in vivo was examined by injecting mice with number of immature thymocytes could reflect increased 5-bromo-2Јdeoxyuridine (BrdU) to label cells in S phase.
seeding of the thymus with precursor cells from the bone marrow, the larger selective increase in the number As shown in Figures 2D and 2E (also Figure 5B and data of mature thymocytes could not. In subsequent experinot shown), proliferation in gut epithelium, spleen, lymph ments, we focused our attention on elucidating the nodes, and thymus was indistinguishable between wildmechanism by which a mutation in E2F-1 leads to a type and E2F-1 Ϫ/Ϫ mice at four to six weeks of age. selective increase in the number of mature thymocytes. By contrast, in older mice differences in proliferation A failure of thymocytes to exit the thymus and colonize between wild-type and E2F-1 Ϫ/Ϫ mice were detected the periphery does not account for the increase in the (see below). Nevertheless, on the basis of the findings number of mature thymocytes in E2F-1 Ϫ/Ϫ mice. First, in younger animals, we can conclude that under many flow cytometric analysis of lymph node cells using anticircumstances E2F-1 is not required for cell proliferation bodies to CD3⑀ or Thy1.2 (markers for T cells) and B220 or cell cycle progression. This may reflect the ability (a marker for B cells) revealed that, as in wild-type mice, of other E2F family members to compensate for the the lymph nodes of E2F-1 Ϫ/Ϫ mice are composed primarabsence of E2F-1.
ily (70% to 80%) of T cells. In addition, E2F-1 Ϫ/Ϫ mice have visibly enlarged, hypercellular lymph nodes ( Figure  Thymus Abnormalities in E2F-1 Ϫ/Ϫ Mice 4; p < 0.01; Student's t test, n ϭ 6 wild-type, n ϭ 6 E2F-1 was found to play a critical role in normal thymic E2F-1 Ϫ/Ϫ ), indicating that E2F-1 Ϫ/Ϫ mice also have an development. Upon dissection, the thymuses of fourincrease in the number of mature T peripheral cells. to six-week-old E2F-1 Ϫ/Ϫ mice were noticeably enlarged Thus, mature T cells effectively exit the thymus of E2F-compared with those of ϩ/ϩ littermates, even though 1 Ϫ/Ϫ mice. other organs were consistently smaller. The ratio of thyAn increase in the rate of cell proliferation within the mus:body weight in E2F-1 Ϫ/Ϫ mice is increased by 25% thymus of young E2F-1 Ϫ/Ϫ mice was also ruled out as relative to wild-type mice ( Figure 3A ; p < 0.03, Student's the explanation for the thymic hypertrophy observed in t test, n ϭ 14 wild-type, n ϭ 12 E2F-1 Ϫ/Ϫ ). The increased these animals. Thymocyte proliferation in vitro in rethymus size reflects a consistent increase in thymic celsponse to stimulation with mitogens was found to be lularity demonstrated by a 55% increase in the number indistinguishable when thymocytes isolated from fourof thymocytes per thymus ( Figure 3B ; p < 0.02, Student's to six-week-old wild-type and E2F-1 Ϫ/Ϫ mice were comt test, n ϭ 10 wild-type, n ϭ 10 E2F-1
). Several mechapared. When the cell cycle distribution of freshly harnisms might explain the increased number of thymovested thymocytes was analyzed, thymocytes from four-to six-week-old wild-type and E2F-1 Ϫ/Ϫ mice were cytes. These include increased seeding of the thymus (B) The cell cycle distributions of exponentially growing wild-type and E2F-1 Ϫ/Ϫ primary embryonic fibroblasts were found to be similar. To assay cell cycle distribution, 75% confluent dishes of fibroblasts were pulse labeled with BrdU for 1 hr, harvested, and fixed. DNA content was assessed by staining with propidium iodide, and DNA synthesis assessed by staining with an antibody to BrdU, as described in Experimental Procedures.
(C) Lymphocytes isolated from the lymph nodes of four-to six-week-old wild-type and E2F-1 Ϫ/Ϫ mice were stimulated in vitro with 1.5 g/ml concanavalin A and 100 U/ml interleukin-2 to assess cell cycle progression to S phase from G0. At various times after stimulation, cell cycle distribution was analyzed, as described in Experimental Procedures. As shown, lymphocytes from wild-type and E2F-1 Ϫ/Ϫ mice responded equally well to concanavalin A and interleukin-2. In other experiments, other stimuli including phorbol myristate acetate and ionomycin or staphyloccocal enterotoxin B and interleukin-2 were also shown to produce similar responses from wild-type and E2F-1 Ϫ/Ϫ lymphocytes.
(D and E) In vivo BrdU labeling (as described in Experimental Procedures) identifies cells in S phase (appearing red) in organs from four-to six-week-old mice. As shown, gut epithelium (D) from four-to six-week-old wild-type (ϩ/ϩ, on the left) and E2F-1 Ϫ/Ϫ (on the right) mice have similar numbers of cells in S phase. Similarly, the spleens (E) from four-to six-week-old wild-type (ϩ/ϩ, on the left) and E2F-1 Ϫ/Ϫ (on the right) mice also have similar numbers of cells in S phase.
found to have similar cell cycle distributions ( Figure 5A ).
Apoptosis was initially examined by monitoring the percent viability of in vitro cultured wild-type and E2F-1
To examine in vivo the fraction of cells in S phase in the thymuses of wild-type and E2F-1 Ϫ/Ϫ mice, four-to sixthymocytes. Only 40% of wild-type thymocytes were still viable after one day in culture. Control experiments week-old mice were injected with BrdU. Wild-type thymuses, as expected, demonstrated labeling predomidemonstrated this loss of viability to be via an apoptotic pathway as measured by DNA end labeling techniques. nantly of cells of the thymic cortex ( Figure 5B ), indicating proliferation of immature thymocytes. E2F-1 Ϫ/Ϫ thyBy contrast, thymocytes from E2F-1 Ϫ/Ϫ littermates maintained 60% viability over the same time period, an inmuses demonstrated a similar distribution and extent of labeling. Together, these experiments indicate that crease of 50% over wild-type ( Figure 6A ). In seven independent experiments comparing a total of 13 wild-type thymocyte proliferation both in vitro and in vivo in fourto six-week-old mice is not affected by the absence and 13 E2F-1 Ϫ/Ϫ littermates four to six weeks of age, the E2F-1 Ϫ/Ϫ thymocytes consistently show increased of E2F-1.
On the other hand, our analysis revealed a clear differviability. This increase in the survival of thymocytes from E2F-1 Ϫ/Ϫ mice is statistically highly significant (p < 0.001, ence in the extent of apoptotic cell death when thymocytes from wild-type and E2F-1 Ϫ/Ϫ mice were compared. (C) Thymocyte expression of the CD4 and CD8 cell surface antigens was examined by flow cytometry. Thymocytes from wild-type and E2F-1 Ϫ/Ϫ mice were labeled with a fluorescein conjugated antibody to CD8 and an R-phycoerythrin conjugated antibody to CD4. CD4 and CD8 expression per cell were analyzed by flow cytometry. In the graphs shown, each dot indicates the CD4 and CD8 expression levels for a single cell. The cell populations are divided into quadrants representing CD4/CD8 double-negative (lower left), CD4/ CD8 double-positive (upper right), CD4 single-positive (upper left), and CD8 single-positive (lower right) populations. The numbers in each quadrant represent the percentage of cells in that quadrant (mean Ϯ SEM). As shown, the more mature CD4 and CD8 singlepositive populations are expanded in the E2F-1 Ϫ/Ϫ mice. The experiment shown represents duplicate measurements from one pair of mice and is representative of seven experiments comparing in total 13 wild-type to 13 E2F-1 Ϫ/Ϫ mice.
(D) Calculation of the absolute number of thymocytes in each subpopulation based on the percentages measured in (C) and the total number of cells per thymus for each animal. E2F-1 Ϫ/Ϫ mice have a small increase in the absolute number of CD4/CD8 double-negative and double-positive thymocytes compared to wild-type. However, E2F-1 Ϫ/Ϫ mice have a larger selective increase in the absolute number of CD4/CD8 single-positive thymocytes compared with wild-type.
ance [ANOVA] of thymocyte viability, n ϭ 13 wild-type, homogeneous subpopulations of wild-type and E2F-1
thymocytes. CD4/CD8 double-positive or single-posin ϭ 13 E2F-1 Ϫ/Ϫ ). In an average thymus, an increase in survival of this magnitude would represent the inapprotive thymocytes from wild-type or E2F-1 Ϫ/Ϫ mice were purified by cell sorting, and their survival in culture was priate survival of over 30 million cells per day.
Since the thymocyte population in E2F-1 Ϫ/Ϫ mice difassayed. Purified CD4 ϩ /CD8 ϩ thymocytes from E2F-1 Ϫ/Ϫ mice displayed a clearly enhanced level of survival fered from that of wild-type mice in that it includes a higher proportion of mature cells, a clear demonstration in culture when compared with their wild-type counterparts ( Figure 6B ), confirming a defect in apoptosis in of a defect in apoptosis in the E2F-1 Ϫ/Ϫ thymocytes required a comparison of the survival of developmentally the E2F-1 deficient thymocytes. By contrast, the survival The observation that CD4 ϩ /CD8 ϩ thymocytes from E2F-1 deficient mice are not as susceptible to apoptosis as wild-type thymocytes raises the possibility that the thymocyte apoptosis both in vitro and in vivo. Moreover, mutant thymocytes might be defective in the process E2F-1 Ϫ/Ϫ thymocytes demonstrate a defect in T cell reof negative selection. Negative selection, the mechaceptor-stimulated apoptosis in vivo, as might be exnism by which thymocytes that recognize self-antigen pected if there is a defect in negative selection in these are eliminated, results from apoptotic loss of self-antimice. The defect in CD4/CD8 double-positive thymocyte gen-recognizing thymocytes stimulated through the T apoptosis in E2F-1 Ϫ/Ϫ mice is likely the cause of the cell receptor. To investigate the possibility that E2F-1 increased production of single-positive thymocytes and might play a role in immunologic negative selection, T T cells in these animals and probably accounts for the cell receptor signalling was stimulated in E2F-1 Ϫ/Ϫ and thymic and lymph node hypertrophy observed in the wild-type mice by the injection of anti-CD3⑀ antibodies E2F-1 Ϫ/Ϫ mice. We conclude that a primary function of and the effect on thymic apoptosis analyzed. This stimu-E2F-1 in vivo is to regulate apoptosis in immature thymolus triggers apoptosis primarily in CD4 ϩ /CD8 ϩ thymocytes. cytes by a mechanism that may mimic negative selection (Owen et al., 1988; Smith et al., 1989; Shi et al., 1991) . Mice were injected with anti-CD3⑀ or control vehicle, Effects of E2F-1 Loss in Older Mice and 16 hr later the fraction of cells undergoing apoptosis
We next considered the possibility that the decreased was determined using an in situ single cell DNA fragmenapoptosis in the CD4 ϩ /CD8 ϩ thymocytes of young E2F-tation assay. As expected the injection of anti-CD3⑀ 1 Ϫ/Ϫ mice and/or the continued absence of E2F-1 in antibodies into wild-type mice led to a significant inthese animals might affect the function of the thymus crease (3-to 6-fold) in thymocyte apoptosis. By contrast, or other organs in older E2F-1 Ϫ/Ϫ mice. To examine the thymocytes of E2F-1 Ϫ/Ϫ mice exhibited significantly less effect of the E2F-1 mutation in older mice, wild-type and (50%) anti-CD3⑀-induced thymocyte apoptosis ( Figure  E2F -1 Ϫ/Ϫ mice 6 to 12 months of age were compared 7; p < 0.002, paired t test, n ϭ 5 wild-type, n ϭ 5 E2F-1 Ϫ/Ϫ ). Thus, E2F-1 Ϫ/Ϫ mice display a defect in CD4 ϩ /CD8 ϩ in a variety of ways. Both the gross and microscopic morphology of liver, gut, brain, cardiac and skeletal muscle, spleen, bone, and kidney were found to be similar in wild-type and E2F-1 Ϫ/Ϫ mice. However, older E2F-1 Ϫ/Ϫ mice displayed moderate testicular atrophy ‫%06ف(‬ reduction in weight, data not shown). The reduction in testicular weight seems to result from a decrease in the number of sperm found in many of the seminiferous tubules. Furthermore, these same tubules are observed to contain an overgrowth of interstitial Leydig cells. While the mechanism of testicular atrophy is uncertain, it is possible that an overgrowth of Leydig cells is the cause of decreased sperm production, and thus the decrease in testicular weight. The most dramatic finding in the older E2F-1 Ϫ/Ϫ mice was again in the thymus. Examination of cell proliferation in 10 wild-type and 11 E2F-1 Ϫ/Ϫ mice by in vivo labeling with BrdU revealed a striking increase in proliferation in the thymus of older E2F-1 Ϫ/Ϫ mice compared with wildtype littermates ( Figure 8A ). The proliferating cells in most of these E2F-1 Ϫ/Ϫ mice maintained normal morphology and were localized to the thymic cortex but not the medulla. The localization of these proliferating thymocytes within the cortex suggests that they are likely to be immature thymocytes. The large increase in the number of proliferating cells in the thymic cortex of older E2F-1 Ϫ/Ϫ mice was seen in all 11 E2F-1 Ϫ/Ϫ thymuses examined, indicating a role for E2F-1 in the control of thymocyte proliferation in older mice. Other tissues, including gut epithelium, spleen, lymph nodes, and liver in the E2F-1 Ϫ/Ϫ mice displayed BrdU labeling indices that were comparable to those seen in wild-type mice ( Figure 8B ). One of the 11 older E2F-1 Ϫ/Ϫ animals, in addition to displaying increased thymic proliferation, Ϫ/Ϫ mice were cultured in vitro for various amounts of time. Cell viability was assayed by trypan blue exclusion. Loss of viability was through apoptosis as demonstrated by early DNA fragmentation measured using in situ nick translation (data not shown). The data shown represent the mean Ϯ SEM for quadruplicate measurements of viability of cultures from two wild-type and two E2F-1 Ϫ/Ϫ mice after 24 hr in vitro and are graphed as viability relative to one of the wildtype controls. These data are representative of experiments comparing, in total, thymocytes from 13 wild-type and 13 E2F-1 Ϫ/Ϫ mice. The difference in survival of thymocytes from wild-type and E2F-1 Ϫ/Ϫ mice is statistically significant with p < 0.001 (two-way ANOVA of thymocyte viability grouped by genotype and days in culture).
(B) and (C) CD4/CD8 double-positive (B) and single-positive (C) thymocytes were purified by fluorescence-activated cell sorting after labeling with fluorescein isothiocyanate-conjugated anti-CD8 and R-phycoerythrin-conjugated anti-CD4. Cell viability over time was assayed by trypan blue exclusion. The data shown represent the mean Ϯ SEM for duplicate measurements at each time point for thymocytes from each animal. All thymocyte cultures had >95% viability at the start of the experiment. These data are representative of experiments comparing, in total, thymocytes from 4 wild-type and 3 E2F-1 Ϫ/Ϫ mice. The difference between the rates of apoptosis of wild-type and E2F-1 Ϫ/Ϫ double-positive, but not single-positive, thymocytes was corroborated by comparing the survival of thymocytes (predominantly double-positive cells) and lymph node cells (predominantly single-positive T cells) from two mice of each genotype (data not shown).
E2F-1 are in many ways normal. E2F-1 Ϫ/Ϫ mice undergo normal embryonic development, are fully viable at birth, and mature to become reproductively competent. The ability of E2F-1 Ϫ/Ϫ mice to do so well may be indicative of the ability of other E2F family members to provide sufficient E2F function for most developmental pathways. Nevertheless, further examination of the E2F-1 Ϫ/Ϫ mice has led to the identification of important nonredundant functions of E2F-1.
Most notably, within one month of birth E2F-1 Ϫ/Ϫ mice display visible enlargement of the thymus and lymph nodes despite a reduction in the size of other organs. These enlarged lymphoid organs reflect an expansion of the population of mature CD4/CD8 single-positive thymocytes and peripheral T cells. This expansion appears to be due to a defect in a normal pathway of apoptosis. The defect in CD4 ϩ /CD8 ϩ thymocyte apoptosis in E2F-1 Ϫ/Ϫ mice is observed in every animal examined, indicating a consistent and important role for role in the process of negative selection. As E2F-1 Ϫ/Ϫ mice age, a second phenotype, characalso contained a region of the thymus with altered morterized by a dramatic increase in thymocyte proliferaphology indicative of a lymphoblastic lymphoma ( Figure  tion , is observed. This aberrant hyperproliferation oc-8C). In vivo labeling of this animal with BrdU demoncurs in the thymic cortex, but not thymic medulla or strated that cells within the tumor were rapidly proliferatlymph nodes, suggesting that it is due to the presence ing. None of the 10 wild-type littermates that were examof proliferating immature thymocytes. The finding that ined contained detectable tumors. More extensive the disruption of E2F-1 function leads to increased thyanalysis of older mice by Yamasaki et al. (1996 [ this mocyte proliferation implies that E2F-1 normally funcissue of Cell]) has revealed sporadic tumorigenesis in a tions as a suppressor of cell proliferation. wide variety of tissues in E2F-1 Ϫ/Ϫ animals, suggesting The fact that the decreased apoptosis detected in that our detection of a tumor in one of the 11 older young mice and the increased cell proliferation seen in animals that we have sacrificed may reflect a real inolder mice both were observed in the thymus suggests crease in the rate of tumorigenesis in these mice. Conthat the two phenotypes may be mechanistically related. sistent with this possibility, we have found that as our For example, inactivation of E2F-1's apoptotic function E2F-1 Ϫ/Ϫ mice age they die at a significantly higher rate may lead indirectly to the hyperproliferation of immature than their wild-type littermates. Although for many the thymocytes. Thus, the role proposed here for E2F-1 may cause of death remains to be elucidated, preliminary be analogous to that of the p53 tumor suppressor gene. evidence suggests that a number of these mice had p53 is believed to play a critical role in suppressing tumors. What we can conclude from our experiments inappropriate cell proliferation. In cells that have underis that as E2F-1 Ϫ/Ϫ mice age they exhibit a consistent gone a mutation that leads to their aberrant proliferation, phenotype of thymic hyperproliferation that at least in p53 somehow triggers cell death. In the absence of p53, one case resulted in the formation of a lymphoblastic for example in the cells of p53-deficient animals, these lymphoma. Together, these findings indicate that inappropriately proliferating cells do not die. Rather, E2F-1 functions in vivo as a suppressor of cell proliferthey expand in number and can give rise to tumors. ation.
Similarly, the observed failure of immature thymocytes in E2F-1 Ϫ/Ϫ mice to undergo normally scheduled apoptosis Discussion may result in the survival of an excessive number of proliferating thymocytes as is observed in older E2F-To investigate the functions of E2F-1, we generated 1 Ϫ/Ϫ mice. Interestingly, this suggests that E2F-1 may play a direct role in regulating apoptosis independent E2F-1 deficient mice. Surprisingly, mice deficient in Wild-type and E2F-1 Ϫ/Ϫ mice 6 to 12 months of age were injected with BrdU to label cells in S phase. Organs were harvested 4 hr later and stained to identify BrdU-incorporating cells (stained red) as described in Experimental Procedures. As shown in (A), wild-type thymuses (ϩ/ϩ, right) had few cells in S phase, while E2F-1 Ϫ/Ϫ thymuses (left) had many cells in S phase. In contrast, other organs, including gut epithelium, as shown in (B), had similar numbers of cells in S phase in wild-type (ϩ/ϩ, right) and E2F-1 Ϫ/Ϫ (left) mice. In 1 of 11 older E2F-1 Ϫ/Ϫ mice a tumor was present, as shown in (C). Tumor tissue is present on the left side of this photograph, while normal thymus is seen on the right. The tumor is identified as a lymphoblastic lymphoma on the basis of standard pathologic criteria including monotony of cell morphology, nucleus size, dispersed chromatin pattern, and scant cytoplasm. Cells of this tumor are rapidly proliferating as demonstrated by the high fraction of BrdU-labeled cells (labeling index of 41%).
of its function as a regulator of cell proliferation. Several sites during G0 or G1. This might lead to aberrant expression of particular cell cycle regulatory genes and recent findings provide support for this possibility. First, we find that the thymuses of young E2F-1 Ϫ/Ϫ mice exhibit inappropriate cell proliferation. A role for E2F-1 in the suppression of thymocyte cell cycle progression might a defect in apoptosis in the absence of any measurable change in cell cycle distribution. Second, in a recent explain the aberrant hyperproliferation seen in the thymus of older E2F-1 Ϫ/Ϫ mice. mutagenesis study E2F-1's roles as a regulator of apoptosis and cell cycle progression were found to be If E2F-1 functions primarily as a suppressor of cell cycle progression, then the defect in apoptosis seen in separable .
Nevertheless, it remains a possibility that E2F-1 funcyoung E2F-1 Ϫ/Ϫ mice could be an indirect consequence of a defect in cell cycle progression. Although we detions primarily as a suppressor of cell proliferation. Consistent with this possibility is the observation that E2F tected no change in the cell cycle distribution of thymocytes in young E2F-1 Ϫ/Ϫ mice, we cannot exclude the DNA binding sites in the promoters of several cell cycle genes function primarily to repress transcription of these possibility that there is a subtle increase in proliferation or progression through the cell cycle in the E2F-1 Ϫ/Ϫ genes during G0 and G1 (Weintraub et al., 1992 (Weintraub et al., , 1995 Neuman et al., 1995) , presumably by binding E2F-Rb cells. If it is necessary that a thymocyte be in a particular phase of the cell cycle to engage apoptosis, a change complexes. Recent data suggest that by repressing transcription E2F-1-Rb complexes suppress entry into in cell cycle distribution caused by the mutation of E2F-1 might lead indirectly to a decrease in apoptosis. S phase . Thus, an E2F-1 deficient cell may be unable to tether Rb to E2F-1 DNA binding A direct role for E2F-1 in either apoptosis or as a hybridization probe was prepared from a 0.9 kb SalI-EcoRI fragment suppressor of cell cycle progression may explain addiof the human E2F-1 cDNA plasmid pSP72-RBAP-1 (Kaelin et al., tional phenotypes that we and Yamasaki et al. (1996) tumors in the E2F-1 Ϫ/Ϫ mice might be the result of a by blunt-end ligation into the XcmI site in exon 3 of E2F-1 and a defect in apoptosis or growth suppression in these cells.
1.7 kb SmaI/EcoRV fragment containing E2F-1 exon 4 was excised.
Although in the thymus E2F-1 plays a consistent role
The disrupted E2F-1 genomic fragment was then inserted into a in preventing abnormal cell proliferation, the sporadic backbone containing a PGK-TK gene to provide a negative senature of the abnormal proliferation seen in other cell lectable marker (Tybulewicz et al., 1991). types suggests that in these cell types random mutations may be required to unmask E2F-1's role in growth
Embryonic Stem Cell Culture and Embryo Manipulation suppression.
J1 ES cell culture, electroporation, and selection of subclones were
The phenotype of the E2F-1 Ϫ/Ϫ mice is surprising performed essentially as described (Li et al., 1992) . Injection of ES given the widely held view that E2Fs function primarily cells into host blastocysts and their surgical introduction into foster mothers were performed essentially as described (Robertson, 1987) .
as positive regulators of cell cycle progression and that E2F-1 overexpression can cause oncogenesis. Our data does not support a unique role for E2F-1 as a promoter
Southern Hybridization and Northern Hybridization
of cell proliferation. Rather, we find that E2F-1 plays a DNA isolated (Laird et al., 1991) (Chomczynski and Sacchi, 1987) and used in standard Northern hybridization (Church and Gilbert, 1984) it functions primarily as a repressor of transcription and using a probe prepared from a 0.9 kb SalI-EcoRI fragment of the a suppressor of cell proliferation. When E2F-1 is overexhuman E2F-1 cDNA (Kaelin et al., 1992) or a 1.3 kb probe prepared pressed there may not be sufficient Rb present in the from a PstI restriction fragment of the rat glyceraldehyde-3-phoscell to bind up all the E2F-1. Under such a circumstance, phate dehydrogenase cDNA (Fort et al., 1985) .
free E2F would be present and might be capable of promoting inappropriate entry into S phase and ulti- (1993) . A genetic analyserum, 0.5 mM ␤-mercaptoethanol, and 1 mM HEPES (pH 7.4). Imsis of the E2F1 gene distinguishes regulation by Rb, p107, and mediately after plating, or at various time intervals, aliquots from adenovirus E4. Mol. Cell. Biol. 13, 6314-6325. replicate wells were mixed with an equal volume of 0.4% trypan DeGregori, J., Kowalik, T., and Nevins, J.R. (1995) . Cellular targets blue, and the concentrations of live and dead cells counted on a for activation by the E2F1 transcription factor include DNA synthehemacytometer. In situ nick translation performed by the method sis-and G1/S-regulatory genes. Mol. Cell. Biol. 15, 4215-4224. of Gold et al. (1993) was used to verify that DNA fragmentation was Devoto, S.H., Mudryj, M., Pines, J., Hunter, T., and Nevins, J.R. an early event in cell death.
(1992). A cyclin A-protein kinase complex possesses sequencespecific DNA binding activity: p33 cdk2 is a component of the E2F-In Vivo Apoptosis cyclin A complex. Cell 68, 167-176. Antibody to CD3⑀ (clone 145-2C11, no azide, low endotoxin formulation, purchased from Pharmingen) diluted in PBS was injected intraDou, Q.P., Markell, P.J., and Pardee, A.B. (1992) . Thymidine kinase peritoneally at a dose of 1.9 to 2.5 g per gram body weight (in a transcription is regulated at G1/S phase by a complex that contains given experiment all mice were injected at the same dose). Control retinoblastoma-like protein and a cdc2 kinase. Proc. Natl. Acad. Sci. mice were injected with a similar volume (0.2 ml) of PBS. Thymocytes USA 89, 3256-3260. were isolated 16 hr later and processed for TUNEL (Gavrieli et al., Duronio, R.J., and O'Farrell, P.H. (1995) . Developmental control of 1992) according to the instructions for the fluorescein Apoptag kit the G1 to S transition in Drosophila: cyclin Eis a limiting downstream (Oncor). Compensation and gates for flow cytometry were set using target of E2F. Genes Dev. 9, 1456-1468. appropriate controls. For negative controls TUNEL was performed Duronio, R.J., O'Farrell, P.H., Xie, J.E., Brook, A., and Dyson, N. omitting the terminal deoxynucleotidyl transferase. As positive con- (1995) . The transcription factor E2F is required for S phase during trols, thymocytes were treated with 1 M dexamethasone for 4 hr Drosophila embryogenesis. Genes Dev. 9, 1445-1455. in vitro, or fixed thymocytes were treated with DNaseI.
Dynlacht, B.D., Flores, O., Lees, J.A., and Harlow, E. (1994) . Differential regulation of E2F transactivation by cyclin/cdk2 complexes.
